Big Health, the leading provider of non-drug digital treatments for mental health, has acquired Limbix, creators of the first, evidence-based digital therapeutic for teens and young adults with symptoms of depression. Since its founding in 2016, Limbix has raised $30 million through its Series A funding round and has built a research-based pipeline of adolescent products. As a result of the transaction, Big Health’s therapeutic portfolio expands to include SparkRx for adolescent depression and an adolescent anxiety product in development, alongside its flagship programs for patients aged 18+: Sleepio, for insomnia, and Daylight, for anxiety.
Read the full article: Big Health Expands into Adolescent Mental Health through Acquisition of Limbix //
Source: https://www.prnewswire.com/news-releases/big-health-expands-into-adolescent-mental-health-through-acquisition-of-limbix-301877281.html